GlobeNewswire Inc.··Not SpecifiedActuate Therapeutics to Unveil Cancer Pipeline Expansion at Citizens Conference
Actuate Therapeutics plans to present at the Citizens Life Sciences Conference on March 10, advancing elraglusib tablet into Phase 1/2 oncology trials launching H2 2026.
ACTUcancer therapypipeline expansion